- The trend backdrop is active with a 10-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
FORTIS
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Fortis Healthcare Limited · Healthcare · Medical Care Facilities
Latest close
955.2 INR
1.1%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 4.6% above the Trend Line and sits at 55.8% of its 52-week range. The latest completed week returned 1.1%, after a -1.2% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers. The latest news-sentiment score is 53/100.
Setup score
60
out of 100
Latest Close
955.2 INR
7 Aug 2026
1W Return
1.1%
latest completed week
4W Return
-1.2%
short-term follow-through
12W Return
-0.9%
quarterly tape
Trend Breadth
53.8%
28 of 52 weeks active
Volume Ratio
2.3x
vs 13-week average
- 1 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.1%
Latest completed week; four-week move -1.2%.
Indicator stack
64/45
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
53/100
31 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 4.6% above the Trend Line and sits at 55.8% of its 52-week range. The latest completed week returned 1.1%, after a -1.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.3x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.7012-week average 0.67
12-week confirmation
Trend active10/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.70Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers
No recent accumulation markers. 1 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -1.2% over four weeks, -0.9% over 12 weeks, and 6.4% over one year. The current trend has remained active for 10 consecutive weeks.
Performance by holding period
Active trend streak10 weeks
Active weeks in one year28
Trend breadth53.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.10Latest activity-pressure read.
Pressure change-88.0%Four-week change in activity pressure.
Leadership3.43Latest relative-leadership reading.
RS change-53.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 94%
Model confidence 88%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength38/100Blend of value, momentum, and quality. Underlying universe rank 63; rank 1 is best.
Value10/100Relative valuation strength. Underlying universe rank 91; rank 1 is best.
Quality91/100Profitability and accounting quality. Underlying universe rank 10; rank 1 is best.
Momentum71/100Medium-term price momentum. Underlying universe rank 30; rank 1 is best.
Growth80/100Revenue and earnings growth. Underlying universe rank 21; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework29/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 69.2x Price divided by trailing earnings.
- Price / sales
- 7.9x Market value relative to trailing revenue.
- EV / EBITDA
- 35.4x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 0.9% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 55.8% Gross profit retained from each unit of revenue.
- Operating margin
- 17.9% Operating profit retained from revenue.
- Free-cash-flow margin
- 7.2% Free cash flow generated from revenue.
- Return on invested capital
- 9.5% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 17.1% Latest one-year revenue growth.
- EPS growth
- 34.6% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 13.7% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 8/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.1% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.1% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 1.4x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment53/100
Weighted news tone is neutral across 31 relevant articles.
2 positive · 29 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-13.5%Distance below the 52-week high.
13-week volatility2.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+7.5%Week of 10 Apr.
Worst week-5.9%Week of 13 Mar.
Latest week+1.1%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains7
Flat weeks0
Modest losses12
Sharp losses2
Recent vol2.0%13-week weekly-return volatility.
Base vol3.4%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew3.0% / -2.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Healthcare
4-week rank61 / 100
Group average1.2%
Trend breadth83.0%
Trend83.0%active weekly trend signals
MD85.0%positive activity pressure
RS73.0%positive relative leadership
Four-week leaders
IndustryIN Medical Care Facilities
4-week rank18 / 21
Group average2.1%
Trend breadth85.7%
Trend85.7%active weekly trend signals
MD76.2%positive activity pressure
RS61.9%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape61/100
Trend, activity pressure, participation, and risk combine to a 61/100 tape read.
Indicator analysis80/100Latest 12-week confirmation: trend 10/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.70; 1 reversal markers Factors52/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 32 SVQF29/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 1126.0 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment53/100Weighted news tone is neutral across 31 relevant articles.
S&P 500 Companies' Quarterly Earnings Growth Eases Amid Healthcare Drop, Oppenheimer Says Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 955.2 INR | 1.1% | 913.2 INR | 669.6 INR | 0.10 | 3.43 | 9.9M | On |
| 31 Jul 2026 | 945.0 INR | -0.4% | 911.5 INR | 665.5 INR | 0.39 | 3.23 | 3.9M | On |
| 24 Jul 2026 | 948.7 INR | -0.3% | 910.5 INR | 661.6 INR | 0.63 | 6.52 | 3.1M | On |
| 17 Jul 2026 | 951.4 INR | -1.6% | 908.9 INR | 657.7 INR | 0.79 | 4.66 | 4.6M | On |
| 10 Jul 2026 | 967.0 INR | -0.7% | 906.9 INR | 653.7 INR | 0.83 | 7.32 | 8.9M | On |
| 3 Jul 2026 | 973.6 INR | 2.1% | 903.8 INR | 649.6 INR | 0.70 | 8.31 | 1.1M | On |
| 26 Jun 2026 | 953.8 INR | -0.8% | 901.0 INR | 645.4 INR | 0.64 | 7.52 | 0 | On |
| 19 Jun 2026 | 961.9 INR | -2.9% | 899.8 INR | 641.3 INR | 0.60 | 9.15 | 1.2M | On |
| 12 Jun 2026 | 990.3 INR | 2.2% | 898.4 INR | 637.1 INR | 0.61 | 14.84 | 934.2K | On |
| 5 Jun 2026 | 968.7 INR | 4.3% | 896.7 INR | 632.7 INR | 0.69 | 14.24 | 1.5M | On |
| 29 May 2026 | 928.5 INR | -3.3% | 898.4 INR | 628.3 INR | 0.78 | 9.29 | 6.3M | Off |
| 22 May 2026 | 960.4 INR | -0.3% | 901.6 INR | 624.1 INR | 0.80 | 12.90 | 5.7M | Off |
| 15 May 2026 | 963.7 INR | 1.2% | 904.1 INR | 619.8 INR | 0.75 | 14.35 | 7.8M | Off |
| 8 May 2026 | 952.3 INR | 3.2% | 908.2 INR | 615.4 INR | 0.44 | 11.29 | 6.0M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.